CONMED Corporation (CNMD)
Return on total capital
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 194,835 | 185,307 | 137,274 | 117,385 | 74,940 | 30,876 | 24,812 | -77,194 | -66,624 | -28,315 | -14,341 | 86,735 | 96,405 | 83,801 | 89,921 | 49,947 | 46,292 | 49,239 | 32,257 | 71,174 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 962,681 | 932,896 | 881,832 | 854,664 | 834,222 | 796,205 | 780,194 | 752,453 | 745,545 | 716,337 | 672,968 | 789,546 | 785,435 | 755,683 | 744,499 | 725,570 | 709,038 | 683,141 | 674,898 | 701,635 |
| Return on total capital | 20.24% | 19.86% | 15.57% | 13.73% | 8.98% | 3.88% | 3.18% | -10.26% | -8.94% | -3.95% | -2.13% | 10.99% | 12.27% | 11.09% | 12.08% | 6.88% | 6.53% | 7.21% | 4.78% | 10.14% |
December 31, 2024 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $194,835K ÷ ($—K + $962,681K)
= 20.24%
CONMED Corporation's return on total capital has shown fluctuations over the past few years, ranging from negative figures to positive double-digit percentages. The trend indicates a level of inconsistency in the company's ability to generate returns on its total capital. The return on total capital was notably low in the mid-year of 2022 and 2023, with negative percentages recorded during those periods, suggesting challenges in utilizing the company's capital efficiently.
However, there has been a significant improvement in the return on total capital since then, with the percentages gradually increasing to reach a noteworthy level by the end of 2024. This positive trend reflects a potential enhancement in CONMED Corporation's capital utilization efficiency and profitability. The most recent data for December 31, 2024, shows a return on total capital of 20.24%, indicating a significant improvement in the company's ability to generate returns on its capital investments.
Overall, it is essential for investors and stakeholders to closely monitor CONMED Corporation's return on total capital to assess the company's operational performance and financial health, considering the fluctuations observed in the past.
Peer comparison
Dec 31, 2024